CD8A and neoplasm: Altogether, our study underpins the importance of functional CD8+ T cells in tumor immunity during PD-1 blockade, eliminates any doubts about effector or off-target effects of antibody treatment for anti-tumor efficacy, and advances the knowledge of specific TIL subpopulations prior to tumor growth inhibition, with the potential to be biomarkers of clinical response.